Organon (OGN) news
Recent news
Logitech International - Reduces share capital to CHF 39.04 mln - SEC filing
Logitech International S.A. has announced a reduction in its share capital to CHF 39.04 million, as disclosed in a recent SEC filing. The move is part of the company’s ongoing corporate governance strategy and reflects adjustments to its capital structure. The filing, submitted under the Securities…
AInvest Wire · 1d agoOrganon Canada's Nduvra gets approval for atopic dermatitis
AInvest Wire · Sep 28, 2026Organon's miudella Snda accepted for FDA review
Organon (NYSE: OGN) has finalized a global licensing agreement for MIUDELLA®, a hormone-free copper intrauterine device (IUD) developed by Sebela Pharmaceuticals, marking a significant step in its contraception portfolio . The product, approved by the U.S. Food and Drug Administration (FDA) on…
AInvest Wire · Sep 14, 2026Organon & Co. - Muidella anticipated to be commercially available in late 2026
AInvest Wire · Sep 14, 2026Organon announces US FDA has accepted for review a SNDA for
AInvest Wire · Sep 14, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.